# Epoch 5 Closure — Strategy Research

> **Type**: Release Checkpoint / Phase Closure（≠ Alpha · ≠ Production · ≠ CXSD Implementation）  
> **Status**: **CLOSED** ✓  
> **Date**: 2026-07-22  
> **Closure ID**: `E5C_V0_1`  
> **Authorization**: Delegation-50K（`授权50次你来决定`）· Option A  
> **Prior**: [`EPOCH_4_CLOSURE.md`](EPOCH_4_CLOSURE.md) — CAP-CTX-001 CLOSED  
> **Positioning（historical）**: [`EPOCH_5_POSITIONING.md`](EPOCH_5_POSITIONING.md)  
> **Checkpoint**: [`EPOCH_5_RELEASE_CHECKPOINT.md`](EPOCH_5_RELEASE_CHECKPOINT.md)  
> **Lifecycle**: [`STRATEGY_LIFECYCLE_FREEZE_CID_002.md`](../research/STRATEGY_LIFECYCLE_FREEZE_CID_002.md) · `LCF_CID_002_V0_1`

## Checkpoint Record（binding）

```text
================================================
EPOCH 5 CLOSURE: CLOSED ✓

CID_002 Lifecycle
  Mechanism Asset:       Research Asset ✓
  Research Bindable:     ✓
  CXSD:                  v0.1 FROZEN ✓
  Implementation:        NONE
  Production Bindable:   WITHHELD
  Alpha:                 NONE
  Production Readiness:  NO

Active phase:            SUPERSEDED → Epoch 6 ACTIVE（2026-07-22）
Successor:               [`EPOCH_6_POSITIONING.md`](EPOCH_6_POSITIONING.md)
                         · [`STRATEGY_RESEARCH_PHASE_AUTHORIZATION_E6.md`](../research/STRATEGY_RESEARCH_PHASE_AUTHORIZATION_E6.md)
CAP-CTX-001 / RC001-B:   remain CLOSED（not reopened）
================================================
```

> **Supersession note**: Epoch 5 terminal statuses remain **locked**.  
> Project activity moved to Epoch 6 via new Strategy Research Phase authorization.  
> This file does **not** reopen Epoch 5 Closed EXPs or upgrade Alpha/Production.

## 1. Final conclusion（locked）

> Epoch 5 完成 CID_002 从机制证据到 Research Bindable 与 CXSD 消费安全合同的治理闭环；交易价值与生产就绪均未主张。

```text
Research Asset + Research Bindable + CXSD Frozen
        ≠
Context Alpha
        ≠
Strategy Improvement
        ≠
Production Approval
```

## 2. Closed loop retained

```text
Mechanism
 ↓
Evidence
 ↓
OOS
 ↓
Research Asset
 ↓
Research Bindable
 ↓
Safety Contract（CXSD-CID_002-v0.1）
```

## 3. Explicit non-claims

```text
❌ Alpha
❌ Production Bindable / Production Readiness
❌ CXSD Implementation（deferred · separate auth）
❌ Trading system started
❌ PnL / Sharpe validation of Context
```

## 4. CXSD boundary（unchanged）

```text
CXSD ≠ Context Alpha
CXSD ≠ Strategy Improvement
CXSD ≠ Risk Model
CXSD ≠ Production Approval

Preserves:
  ContextState → Consumer → Permission/Filter/Monitor

Blocks drift to:
  ContextState → Prediction → Signal → Position
```

## 5. Deferred options（not opened）

```text
B. Authorize CXSD Implementation Charter
   （conformance only: validator · ACL · audit · violation · evidence）
   Evaluation: Contract Compliance + Auditability + Failure Safety
   NOT PnL/Sharpe/DD
```

## 6. Successor rule

```text
Any new Strategy Research activity requires a NEW phase authorization.
This Closure does not grant continuous Epoch 5 work.
```

### Phase authorization note

[`STRATEGY_RESEARCH_PHASE_AUTHORIZATION.md`](../research/STRATEGY_RESEARCH_PHASE_AUTHORIZATION.md) granted Epoch 5 start.  
**E5C_V0_1 closes that phase activity.** Re-entry needs a new Authorize command.

## Hard guarantees

```text
✓ No Observation / backtest under Delegation-50K
✓ No CXSD code implementation
✓ No Production / Alpha stamp
✓ CAP-CTX-001 and RC001-B not reopened
```

## Revision record

| Date | Change |
|------|--------|
| 2026-07-22 | E5C_V0_1 CLOSED under Delegation-50K |
